Trial intelligence / Profile preview

Deep vs Restricted Neuromuscular Blockade in Spinal Surgery

NCT02724111Phase 4Completed

Sponsor
Korea University Guro Hospital
Start
May 2016
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rocuronium in Spinal disease, sponsored by Korea University Guro Hospital. Started May 2016; status: completed.

02

Drugs

rocuronium
03

Conditions

Spinal disease

Beyond the preview

Go deeper on NCT02724111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02724111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call